MY153729A - Oral composition comprising a cooling agent - Google Patents
Oral composition comprising a cooling agentInfo
- Publication number
- MY153729A MY153729A MYPI2010001719A MYPI20101719A MY153729A MY 153729 A MY153729 A MY 153729A MY PI2010001719 A MYPI2010001719 A MY PI2010001719A MY PI20101719 A MYPI20101719 A MY PI20101719A MY 153729 A MY153729 A MY 153729A
- Authority
- MY
- Malaysia
- Prior art keywords
- cooling agent
- oral composition
- formulation
- present
- endothermic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/055—Phenols the aromatic ring being substituted by halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/24—Thermal properties
- A61K2800/244—Endothermic; Cooling; Cooling sensation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
THE PRESENT INVENTION RELATES TO A FORMULATION COMPRISING AN ENDOTHERMIC COOLING AGENT SELECTED FROM THE GROUP CONSISTING OF XYLITOL, SORBITOL, MANNITOL AND ERYTHRITOL HAVING A HEAT OF ENTHALPY BETWEEN -10CAL/G AND -100CAL/G, AND ONE OR MORE ACTIVE AGENTS WHEREIN THE ENDOTHERMIC AGENT IS PRESENT IN THE FORMULATION AT AN AMOUNT LESS THAN 10% W/W.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0720425A GB2453770A (en) | 2007-10-19 | 2007-10-19 | Oral composition comprising a cooling agent |
Publications (1)
Publication Number | Publication Date |
---|---|
MY153729A true MY153729A (en) | 2015-03-13 |
Family
ID=38814082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2010001719A MY153729A (en) | 2007-10-19 | 2008-10-17 | Oral composition comprising a cooling agent |
Country Status (17)
Country | Link |
---|---|
US (2) | US9314428B2 (en) |
EP (1) | EP2209465B1 (en) |
KR (1) | KR101580139B1 (en) |
CN (1) | CN101827582A (en) |
AU (1) | AU2008313488B2 (en) |
BR (1) | BRPI0817999A2 (en) |
CA (1) | CA2702688A1 (en) |
ES (1) | ES2595102T3 (en) |
GB (1) | GB2453770A (en) |
MX (1) | MX2010004194A (en) |
MY (1) | MY153729A (en) |
PL (1) | PL2209465T3 (en) |
RU (4) | RU2524640C2 (en) |
SG (1) | SG186627A1 (en) |
TW (1) | TW200930355A (en) |
WO (1) | WO2009050490A1 (en) |
ZA (1) | ZA201002637B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201001048D0 (en) * | 2010-01-22 | 2010-03-10 | Aesica Pharmaceuticals Ltd | Antiseptic gum |
GB201004890D0 (en) * | 2010-03-23 | 2010-05-05 | Cadbury Uk Ltd | Confectionery product containing active and/or reactive components and methods of production thereof |
LT2621894T (en) * | 2010-09-27 | 2017-01-25 | E. I. Du Pont De Nemours And Company | Method for preparing 2-amino-n-(2,2,2-trifluoroethyl) acetamide |
GB201215988D0 (en) * | 2012-09-07 | 2012-10-24 | Reckitt Benckiser Healthcare Int Ltd | Pharmaceutical compositions comprising flurbiprofen |
CN113995721A (en) * | 2020-07-27 | 2022-02-01 | 德国吉麦医疗技术有限公司 | Ambroxol hydrochloride oral spray solution and preparation method thereof |
CN114617293B (en) * | 2022-03-17 | 2023-08-18 | 湖北中烟工业有限责任公司 | Low-smoke cool-resistance cooling material for cigarette filter tips |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3123528A (en) * | 1964-03-03 | New therapeutic compositions | ||
BR9710265A (en) * | 1996-07-12 | 1999-08-10 | Daiichi Seiyaku Co | Compression molded materials quickly disintegrated and process for producing them |
JPH10194926A (en) * | 1997-01-09 | 1998-07-28 | Shiseido Co Ltd | Rhigotic composition |
WO1999055373A1 (en) * | 1998-04-24 | 1999-11-04 | Fuji Chemical Industry Co., Ltd. | Saccharide-containing compositions |
US20030211136A1 (en) * | 1998-09-25 | 2003-11-13 | Neema Kulkarni | Fast dissolving orally consumable films containing a sweetener |
GB9908014D0 (en) * | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
US7510728B2 (en) * | 2000-10-06 | 2009-03-31 | Takeda Pharmaceutical Company Limited | Solid preparations |
US20070196496A1 (en) * | 2002-04-16 | 2007-08-23 | Michael Farber | Delivery systems for functional ingredients |
US20070098648A1 (en) * | 2002-11-05 | 2007-05-03 | Haley Jeffrey T | Treating mouth sores caused by dental braces with blobs of hydrophilic gums |
US20060011571A1 (en) * | 2002-11-08 | 2006-01-19 | Silver Brian H | Artificial nipple with reinforcement |
US20040180110A1 (en) * | 2003-03-14 | 2004-09-16 | Atul Mistry | Chewing gum and confectionery compositions containing an endothermic agent |
WO2004089343A1 (en) * | 2003-04-09 | 2004-10-21 | Ranbaxy Laboratories Limited | Water soluble tablets |
AR044007A1 (en) * | 2003-04-11 | 2005-08-24 | Newron Pharmaceuticals Inc | METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE |
GB0320854D0 (en) * | 2003-09-05 | 2003-10-08 | Arrow No 7 Ltd | Buccal drug delivery |
US9271904B2 (en) * | 2003-11-21 | 2016-03-01 | Intercontinental Great Brands Llc | Controlled release oral delivery systems |
GB0400774D0 (en) * | 2004-01-14 | 2004-02-18 | Boots Healthcare Int Ltd | Pharmaceutical composition |
WO2006063189A2 (en) * | 2004-12-10 | 2006-06-15 | Novartis Ag | Multi-layered chewing gum tablet with quick disintegration layer |
PE20070698A1 (en) * | 2005-11-14 | 2007-08-17 | Teijin Pharma Ltd | INTRAORAL RAPID DISGREGATION TABLET CONTAINING AMBROXOL HYDROCHLORIDE |
US20070134493A1 (en) * | 2005-12-08 | 2007-06-14 | Kanji Meghpara | Compositions and capsules with stable hydrophilic layers |
EP2015761A4 (en) * | 2006-03-29 | 2009-07-29 | Naveh Pharma 1996 Ltd | Methods and composition for treating sore throat |
US20090081294A1 (en) * | 2007-09-26 | 2009-03-26 | Gin Jerry B | Sustained release dosage form for lubricating an oral cavity |
-
2007
- 2007-10-19 GB GB0720425A patent/GB2453770A/en not_active Withdrawn
-
2008
- 2008-10-16 TW TW097139697A patent/TW200930355A/en unknown
- 2008-10-17 MX MX2010004194A patent/MX2010004194A/en active IP Right Grant
- 2008-10-17 CA CA2702688A patent/CA2702688A1/en not_active Abandoned
- 2008-10-17 RU RU2010118323/15A patent/RU2524640C2/en active
- 2008-10-17 CN CN200880111672A patent/CN101827582A/en active Pending
- 2008-10-17 AU AU2008313488A patent/AU2008313488B2/en active Active
- 2008-10-17 KR KR1020107010171A patent/KR101580139B1/en active IP Right Grant
- 2008-10-17 EP EP08839344.2A patent/EP2209465B1/en active Active
- 2008-10-17 US US12/738,178 patent/US9314428B2/en active Active
- 2008-10-17 MY MYPI2010001719A patent/MY153729A/en unknown
- 2008-10-17 WO PCT/GB2008/003543 patent/WO2009050490A1/en active Application Filing
- 2008-10-17 ES ES08839344.2T patent/ES2595102T3/en active Active
- 2008-10-17 BR BRPI0817999-9A patent/BRPI0817999A2/en not_active Application Discontinuation
- 2008-10-17 PL PL08839344T patent/PL2209465T3/en unknown
- 2008-10-17 SG SG2012089728A patent/SG186627A1/en unknown
-
2010
- 2010-04-15 ZA ZA2010/02637A patent/ZA201002637B/en unknown
-
2014
- 2014-05-28 RU RU2014121726/15A patent/RU2014121726A/en unknown
-
2016
- 2016-04-18 US US15/131,314 patent/US9764034B2/en active Active
-
2017
- 2017-07-07 RU RU2017124005A patent/RU2017124005A/en unknown
- 2017-07-07 RU RU2020113212A patent/RU2020113212A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2702688A1 (en) | 2009-04-23 |
AU2008313488B2 (en) | 2013-05-30 |
PL2209465T3 (en) | 2017-01-31 |
SG186627A1 (en) | 2013-01-30 |
KR101580139B1 (en) | 2015-12-28 |
AU2008313488A1 (en) | 2009-04-23 |
EP2209465B1 (en) | 2016-07-06 |
RU2020113212A (en) | 2020-05-29 |
TW200930355A (en) | 2009-07-16 |
GB0720425D0 (en) | 2007-11-28 |
WO2009050490A1 (en) | 2009-04-23 |
US20160228552A1 (en) | 2016-08-11 |
CN101827582A (en) | 2010-09-08 |
US9764034B2 (en) | 2017-09-19 |
GB2453770A (en) | 2009-04-22 |
RU2010118323A (en) | 2011-11-20 |
ES2595102T3 (en) | 2016-12-27 |
KR20100086998A (en) | 2010-08-02 |
ZA201002637B (en) | 2011-06-29 |
RU2017124005A3 (en) | 2019-01-10 |
RU2017124005A (en) | 2019-01-10 |
RU2524640C2 (en) | 2014-07-27 |
MX2010004194A (en) | 2010-05-14 |
RU2014121726A (en) | 2015-12-10 |
US9314428B2 (en) | 2016-04-19 |
BRPI0817999A2 (en) | 2015-04-14 |
US20100216830A1 (en) | 2010-08-26 |
EP2209465A1 (en) | 2010-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY153729A (en) | Oral composition comprising a cooling agent | |
HRP20190198T1 (en) | Formulations which stabilize and inhibit percipitation of immunogenic compositions | |
UA84318C2 (en) | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists, pharmaceutical composition based thereon | |
NO20081593L (en) | Depot Composition | |
WO2009100441A3 (en) | Depot formulations | |
BRPI0400721A (en) | Sucralose-containing compositions | |
WO2009105740A3 (en) | Absorbent article comprising lotion composition comprising a cooling agent | |
MY153658A (en) | Methods of making compositions comprising films | |
ATE537828T1 (en) | PSYCHOTROPIC AGENTS AND FOODS FOR PROMOTING HEALTH CONTAINING NEFERINE | |
TW200740427A (en) | Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate | |
MX2009004439A (en) | Ibuprofen composition. | |
BRPI0414428A (en) | pharmaceutical compositions | |
UA87841C2 (en) | Topical composition containing ambroxol | |
TW200730178A (en) | Aerosol formulations for the inhalation of β-agonists | |
HRP20151202T1 (en) | Oral formulation of metadoxine | |
IL180144A0 (en) | Compositions comprising strontium and vitamin d and uses thereof | |
WO2007143557A3 (en) | Compounds and methods for treating mammalian gastrointestinal parasitic infections | |
TW200738283A (en) | Formulations of conjugated estrogens and bazedoxifene | |
DE502006007702D1 (en) | TABLETIC RETARD PREPARATION CONTAINING CINNARIC ACID AND DIMENHYDRINATE AGAINST DIFFICULTY | |
WO2009117401A3 (en) | Compositions for site-specific delivery of imatinib and methods of use | |
BR0311327A (en) | Oxcarbazepine-containing pharmaceutical composition with sustained release of an active ingredient | |
UA87312C2 (en) | COMPOSITION FOR AEROSOL INHALATION OF β-AGONISTS | |
TW200738239A (en) | Stable solid formulation of sertindole | |
JP2008541745A5 (en) | ||
DE502006007693D1 (en) | PELLETFUL REATRD PREPARATION CONTAINING CINNARIZIN AND DIMENHYDRINATE AGAINST DIFFICULTY |